108 related articles for article (PubMed ID: 26725317)
1. Identification of Phosphoribosyl-AMP cyclohydrolase, as drug target and its inhibitors in Brucella melitensis bv. 1 16M using metabolic pathway analysis.
Gupta M; Prasad Y; Sharma SK; Jain CK
J Biomol Struct Dyn; 2017 Feb; 35(2):287-299. PubMed ID: 26725317
[TBL] [Abstract][Full Text] [Related]
2. Modeling, molecular dynamics, and docking assessment of transcription factor rho: a potential drug target in Brucella melitensis 16M.
Pradeepkiran JA; Kumar KK; Kumar YN; Bhaskar M
Drug Des Devel Ther; 2015; 9():1897-912. PubMed ID: 25848225
[TBL] [Abstract][Full Text] [Related]
3. Complete genome-wide screening and subtractive genomic approach revealed new virulence factors, potential drug targets against bio-war pathogen Brucella melitensis 16M.
Pradeepkiran JA; Sainath SB; Kumar KK; Bhaskar M
Drug Des Devel Ther; 2015; 9():1691-706. PubMed ID: 25834405
[TBL] [Abstract][Full Text] [Related]
4. Novel Vaccine Candidates against Brucella melitensis Identified through Reverse Vaccinology Approach.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
OMICS; 2015 Nov; 19(11):722-9. PubMed ID: 26479901
[TBL] [Abstract][Full Text] [Related]
5. Shape-based virtual screening, docking, and molecular dynamics simulations to identify Mtb-ASADH inhibitors.
Kumar R; Garg P; Bharatam PV
J Biomol Struct Dyn; 2015; 33(5):1082-93. PubMed ID: 24875451
[TBL] [Abstract][Full Text] [Related]
6. In silico approach towards identification of potential inhibitors of Helicobacter pylori DapE.
Mandal RS; Das S
J Biomol Struct Dyn; 2015; 33(7):1460-73. PubMed ID: 25204745
[TBL] [Abstract][Full Text] [Related]
7. Protein interaction network analysis--approach for potential drug target identification in Mycobacterium tuberculosis.
Kushwaha SK; Shakya M
J Theor Biol; 2010 Jan; 262(2):284-94. PubMed ID: 19833135
[TBL] [Abstract][Full Text] [Related]
8. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
Uddin R; Masood F; Azam SS; Wadood A
Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
[TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Methanobacterium thermoautotrophicum phosphoribosyl-AMP cyclohydrolase HisI.
Sivaraman J; Myers RS; Boju L; Sulea T; Cygler M; Jo Davisson V; Schrag JD
Biochemistry; 2005 Aug; 44(30):10071-80. PubMed ID: 16042384
[TBL] [Abstract][Full Text] [Related]
10. Comparative proteome analysis of laboratory grown Brucella abortus 2308 and Brucella melitensis 16M.
Eschenbrenner M; Horn TA; Wagner MA; Mujer CV; Miller-Scandle TL; DelVecchio VG
J Proteome Res; 2006 Jul; 5(7):1731-40. PubMed ID: 16823981
[TBL] [Abstract][Full Text] [Related]
11. A comparative modeling and molecular docking study on Mycobacterium tuberculosis targets involved in peptidoglycan biosynthesis.
Fakhar Z; Naiker S; Alves CN; Govender T; Maguire GE; Lameira J; Lamichhane G; Kruger HG; Honarparvar B
J Biomol Struct Dyn; 2016 Nov; 34(11):2399-417. PubMed ID: 26612108
[TBL] [Abstract][Full Text] [Related]
12. Identification of OtpR regulated sRNAs in Brucella melitensis expressed under acidic stress and their roles in pathogenesis and metabolism.
Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
Comp Immunol Microbiol Infect Dis; 2017 Feb; 50():40-47. PubMed ID: 28131377
[TBL] [Abstract][Full Text] [Related]
13. Response regulator GacA and transcriptional activator RhlR proteins involved in biofilm formation of Pseudomonas aeruginosa are prospective targets for natural lead molecules: Computational modelling, molecular docking and dynamic simulation studies.
Skariyachan S; Ravishankar R; Gopal D; Muddebihalkar AG; Uttarkar A; Praveen PKU; Niranjan V
Infect Genet Evol; 2020 Nov; 85():104448. PubMed ID: 32622078
[TBL] [Abstract][Full Text] [Related]
14. In-silico analysis of Sirt2 from Schistosoma mansoni: structures, conformations, and interactions with inhibitors.
Singh R; Singh S; Pandey PN
J Biomol Struct Dyn; 2016 May; 34(5):1042-51. PubMed ID: 26108803
[TBL] [Abstract][Full Text] [Related]
15. High Throughput Virtual Screening to Identify Novel natural product Inhibitors for MethionyltRNA-Synthetase of Brucella melitensis.
Kumari M; Chandra S; Tiwari N; Subbarao N
Bioinformation; 2017; 13(1):8-16. PubMed ID: 28479744
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Identification of Immunodominant Proteins of Brucella abortus and Brucella melitensis Using Antibodies in the Sera from Naturally Infected Hosts.
Wareth G; Eravci M; Weise C; Roesler U; Melzer F; Sprague LD; Neubauer H; Murugaiyan J
Int J Mol Sci; 2016 Apr; 17(5):. PubMed ID: 27144565
[TBL] [Abstract][Full Text] [Related]
17. Identification of druggable targets for Acinetobacter baumannii via subtractive genomics and plausible inhibitors for MurA and MurB.
Kaur N; Khokhar M; Jain V; Bharatam PV; Sandhir R; Tewari R
Appl Biochem Biotechnol; 2013 Sep; 171(2):417-36. PubMed ID: 23846799
[TBL] [Abstract][Full Text] [Related]
18. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
Uddin R; Saeed K; Khan W; Azam SS; Wadood A
Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
[TBL] [Abstract][Full Text] [Related]
19. Structural and dynamical aspects of Streptococcus gordonii FabH through molecular docking and MD simulations.
Shamim A; Abbasi SW; Azam SS
J Mol Graph Model; 2015 Jul; 60():180-96. PubMed ID: 26059477
[TBL] [Abstract][Full Text] [Related]
20. In silico study and validation of phosphotransacetylase (PTA) as a putative drug target for Staphylococcus aureus by homology-based modelling and virtual screening.
Morya VK; Dewaker V; Kim EK
Appl Biochem Biotechnol; 2012 Dec; 168(7):1792-805. PubMed ID: 23054816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
